The DNA-pooling technique allowed for the identification of three novel mutations responsible for afibrinogenemia [8]

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 11, 2005, Pages 2591-2593

  Monaldini, L ^a   Asselta, R ^a   Malcovati, M ^a   Tenchini, M L ^a   Duga, S ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b Department of Biology and Genetics for Medical Sciences ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; FIBRIN MONOMER; FIBRINOGEN; NUCLEOTIDE; PLASMA PROTEIN; TRINUCLEOTIDE;

AFIBRINOGENEMIA; ALLELE; CONGENITAL BLOOD CLOTTING DISORDER; DISEASE SEVERITY; DNA POLYMORPHISM; ELECTROPHORESIS; FIBRINOGEN DEFECT; GENE CLUSTER; GENE DELETION; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC DISORDER; GENETIC HETEROGENEITY; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; LETTER; LIVER CELL; MARKER GENE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS;

AFIBRINOGENEMIA; DNA; DNA MUTATIONAL ANALYSIS; FIBRINOGEN; GENETIC SCREENING; GENOTYPE; HOMOZYGOTE; HUMANS; MUTATION;

EID: 28444436586     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01613.x     Document Type: Letter

References (13)

1. Lak M, Keihani M, Elahi F, Peyvandi F, Mannucci PM. Bleeding and thrombosis in 55 patients with inherited afibrinogemia. Br J Haematol 1999; 107: 204-6.
2. Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood 2004; 104: 1243-52.
3. Mosesson MW. Fibrinogen structure and fibrin clot assembly. Semin Thromb Hemost 1998; 24: 169-74.
4. UCSC Genome Browser. Available at http://genome.ucsc.edu/. (accessed 12 July 2005).
5. The Fibrinogen Database. Available at http://www.geht.org/ databaseang/fibrinogen/ (accessed 12 July 2005).
6. Sham P, Bader JS, Craig I, O'Donovan M, Owen M. DNA pooling: a tool for large-scale association studies. Nat Rev Genet 2002; 3: 862-71.
7. Peyvandi F, Mannucci PM. Rare coagulation disorders. Thromb Haemost 1999; 82: 1207-14.
8. Duga S, Asselta R, Santagostino E, Zeinali S, Simonic T, Malcovati M, Mannucci PM, Tenchini ML. Missense mutations in the human beta fibrinogen gene cause congenital afibrinogenemia by impairing fibrinogen secretion. Blood 2000; 95: 1336-41.
9. Menegatti M, Asselta R, Duga S, Malcovati M, Bucciarelli P, Mannucci PM, Tenchini ML. Identification of four novel polymorphisms in the Aalpha and gamma fibrinogen genes and analysis of association with plasma levels of the protein. Thromb Res 2001; 103: 299-307.
10. Asselta R, Duga S, Spena S, Santagostino E, Peyvandi F, Piseddu G, Targhetta R, Malcovati M, Mannucci PM, Tenchini ML. Congenital afibrinogenemia: mutations leading to premature termination codons in fibrinogen A alpha-chain gene are not associated with the decay of the mutant mRNAs. Blood 2001; 98: 3685-92.
11. Cartegni L, Chew SL, Krainer AR. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 2002; 3: 285-98.
12. Asselta R, Duga S, Simonic T, Malcovati M, Santagostino E, Giangrande PL, Mannucci PM, Tenchini ML. Afibrinogenemia: first identification of a splicing mutation in the fibrinogen gamma chain gene leading to a major gamma chain truncation. Blood 2000; 96: 2496-500.
13. Neerman-Arbez M, Vu D, Abu-Libdeh B, Bouchardy I, Morris MA. Prenatal diagnosis for congenital afibrinogenemia caused by a novel nonsense mutation in the FGB gene in a Palestinian family. Blood 2003; 101: 3492-4.